Chao Xing Selected Research

Chao Xing Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 01/2014
8	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2015
6	Inflammation (Inflammations) 12/2021 - 01/2019
5	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2016
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2017
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2009
4	Fuchs' Endothelial Dystrophy 01/2020 - 02/2015
4	Fibrosis (Cirrhosis) 01/2019 - 09/2011
4	Non-alcoholic Fatty Liver Disease 01/2019 - 11/2012
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2010 - 05/2007
3	Carcinogenesis 01/2022 - 01/2017
3	Hypoxia (Hypoxemia) 01/2021 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2017
3	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021 - 01/2016
3	Infections 01/2020 - 10/2015
3	Disease Progression 01/2020 - 01/2014
3	Myocardial Infarction 01/2019 - 01/2011
3	Hypertension (High Blood Pressure) 01/2018 - 04/2006
3	Hypertriglyceridemia 01/2017 - 07/2016
3	Liver Diseases (Liver Disease) 12/2015 - 05/2010
2	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2015
2	Starvation 01/2022 - 01/2020
2	Myocarditis (Carditis) 12/2021 - 09/2007
2	Fatty Liver 11/2021 - 02/2015
2	Triple Negative Breast Neoplasms 10/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 08/2021 - 10/2018
2	Atrophy 01/2021 - 07/2016
2	Glaucoma 01/2021 - 01/2018
2	Cysts 01/2021 - 01/2016
2	Glioma (Gliomas) 10/2020 - 01/2020
2	Progeria (Hutchinson Gilford Syndrome) 10/2020 - 09/2017
2	Lipodystrophy 09/2017 - 12/2010
2	Hyperglycemia 07/2016 - 02/2015
2	Atherosclerosis 02/2015 - 03/2010
2	Idiopathic Pulmonary Fibrosis 09/2011 - 05/2010
1	Lymphatic Metastasis 01/2022
1	Alcoholic Fatty Liver 01/2022
1	Myopia 01/2022
1	Vascular Calcification 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2021
1	Pathologic Processes 12/2021
1	Bites and Stings (Sting) 11/2021
1	Genetic Risk Score 09/2021
1	Hypoproteinemia 05/2021

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
10	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
7	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2016
6	Small Interfering RNA (siRNA)IBA 01/2022 - 03/2018
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
6	Biological ProductsIBA 12/2021 - 12/2019
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2016
5	Long Noncoding RNAIBA 12/2021 - 01/2018
5	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020 - 05/2007
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2019
4	Interleukin-1 (Interleukin 1)IBA 12/2021 - 01/2018
4	ChromatinIBA 01/2021 - 01/2017
4	Retinaldehyde (Retinal)IBA 01/2021 - 04/2006
4	RNA Polymerase II (RNA Polymerase B)IBA 01/2020 - 01/2018
3	LipidsIBA 01/2022 - 02/2015
3	CytokinesIBA 12/2021 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2010
3	Triglycerides (Triacylglycerol)IBA 11/2016 - 02/2015
2	Therapeutic UsesIBA 01/2022 - 02/2019
2	ferruginolIBA 01/2021 - 11/2017
2	Particulate MatterIBA 01/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2014
2	Lamin Type A (Lamin A)IBA 10/2020 - 09/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2017
2	AndrogensIBA 01/2020 - 01/2017
2	Fish OilsIBA 11/2016 - 07/2016
2	Alanine Transaminase (SGPT)IBA 03/2016 - 02/2012
1	Hydroxyl RadicalIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Sodium-Phosphate Cotransporter Proteins (Sodium-Phosphate Cotransporter)IBA 01/2022
1	Antisense OligonucleotidesIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	PolyaminesIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	PNU-282987IBA 12/2021
1	extracellular matrix receptorIBA 12/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2021
1	Insulin ReceptorIBA 11/2021
1	SaporinsIBA 10/2021
1	oxidized low density lipoproteinIBA 09/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 11/2016
3	Radiotherapy 01/2018 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Brachytherapy 01/2022 - 01/2021
2	Immunotherapy 01/2020 - 10/2017
1	RNAi Therapeutics 01/2022
1	Salvage Therapy 01/2022
1	Vagotomy 12/2021
1	Castration 12/2021